<?xml version="1.0" encoding="UTF-8"?>
<p>The efficacy of nasal administration against neurotropic viral effects was tested on mice infected by herpes simplex virus type 1 (HSV-1). In particular, mice models of HSV-1 encephalitis received an intranasal pretreatment with the immunostimulant polyinosinic:polycytidylic acid (poly I:C) using a saline vehicle, and they showed a significantly higher mean life expectancy and an increased rate of survival than mice with an intraperitoneal pretreatment of poly I:C [
 <xref rid="B83-pharmaceutics-10-00039" ref-type="bibr">83</xref>].
</p>
